DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Novartis (NYSE: NVS)

104.28 -1.22 (-1.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVS $104.28 -1.16%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $104.53
Previous Close $105.50
Daily Range $103.95 - $104.78
52-Week Range $83.71 - $105.82
Market Cap $250.1B
P/E Ratio 28.51
Dividend (Yield) $2.67 (2.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 821,026
Average Daily Volume 1,427,411
Current FY EPS $5.25




Drug Makers

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website:

News & Commentary Rss Feed

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis AG (NVS) Earnings Report: Q1 2015 Conference Call Transcript

Novartis's (NVS) CEO Joe Jimenez on Q1 2015 Results - Earnings Call Transcript

Amgen Reports An Upbeat Q1 Earnings

Novartis (NVS) Beats on Earnings & Revenues - Tale of the Tape

Novartis Posts Higher Q1 Profit

Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $104.28 (-1.16%)
Current stock: NVS
JNJ $101.08 (0.62%)
Current stock: JNJ
MRK $57.60 (0.16%)
Current stock: MRK
GSK $46.59 (0.60%)
Current stock: GSK